1[1]Hiromitsu Kumada.Long- term treatment of chronic hepatitis C with glycyrrhizin[stronger neo- minophagen C(SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma[J]. Oncology, 2002,62,(1):94.
2[2]Ohtsuki K.Separation of phospholipase A2 in Habu snake venom by glycyrrhizin(GL)- affinity column chromatography and identification of a GL- sensitive enzyme[J]. Biol Pharm Bull, 1998,21:574.
3[3]Shimoyama Y.Physiological correlation between glycyrrhizin,glycyrrhizin- binding lipoxygenase and casein kinase Ⅱ [J].FFBS Lett, 1996,391:238.
4[4]Zhang Y.Bidirectional control by glycurrhizin of the growth response of lymphocytes stimulated through a receptor- bypassed pathway[J]. Immunol Lett ,1992,32:147.
5[5]Kimura M.Selective activation of extrathymic T cells in the liver by glycyrrhizin[J]. Biotherapy ,1992,5:167.
6[6]Takahara T,Watanabe A, Shiraki K.Effects of glycyrrhizin on hepatitis B surface antigen: a biochemical and morphological study[J]. J Hepatol, 1994,21:601.
7[7]Sato H, Goto W, Yamamura J.Therapeutic basis of glycyrrhizin on chronic hepatitis B[J]. Antivir Res,1996,30:171.
8[8]Iino S.Therapeutic effects of stronger neo- minopha_ gen C at different doses on chronic hepatitis and liver cirrhosis[J]. Hepatol Res ,2001,19:31.
9[9]MacKenzie MA.The influence on glycyrrhetinic acid on plasma cortisol and cortisone in healthy young volunteers[J]. J Clin Endocrinol Metab ,1990,70:1 637.
4Nagaki M ,Iwai H ,Naili T, et al. High Levels of serum interleukin - 10 and tumor necrosis factor - alpha are associated with fatality in ful- miuant hepatitis [ J ]. J Infect Dis,2000,182 (4) : 1103 - 1108.
